ClinicalTrials.gov
public full text
Public Domain
Effect of Nafamostat on Postreperfusion Syndrome (PRS)
This study intends to see the effect of nafamostat on the attenuation of postreperfusion syndrome (PRS) that frequently occurs during liver transplantation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF)#1000628
- Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey#347698
- Transoesophageal Echocardiography in Liver Transplantation#915644
- Hypotension Prediction Index in Patients Undergoing Liver Transplantation#802196
- Effects of massive transfusion (10-20 litres) versus ultramassive transfusion (≥20 litres) on mortality in adult liver transplant recipients: A propensity-score matched study#214329
Record · ID 1164916
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive